Abstract
No public abstract is available from the verified source records.
Open public full textRights: UNKNOWN · https://www.elsevier.com/tdm/userlicense/1.0/ · Source: journal-auto-sync:external:CROSSREF_ISSN
Mark Yen-Ping Kuo, Hong-Yuan Hsu, Sang-Heng Kok, Ru-Cheng Kuo, Hsian Yang, Liang-Jiunn Hahn, Chun-Pin Chiang
Abstract
Rights: UNKNOWN · https://www.elsevier.com/tdm/userlicense/1.0/ · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age
10.1016/0092-8674(94)90543-6 · 1994
Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer
10.1615/critreveukargeneexpr.v5.i2.20 · 1995
Inhibitors of mammalian G1 cyclin-dependent kinases
10.1101/gad.9.10.1149 · 1995
Cancer cell cycles
10.1126/science.274.5293.1672 · 1996
p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
10.1016/s0002-9440(10)65277-7 · 1999
Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family
10.1016/0092-8674(91)90044-y · 1991
A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells
10.1128/mcb.14.6.3683 · 1994
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
10.1016/0092-8674(94)90573-8 · 1994
Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
10.1016/0092-8674(94)90572-x · 1994
Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle
10.1126/science.272.5263.877 · 1996
unpaywall
Confidence 95%
datacite
Confidence 0%
Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin
10.1038/372570a0 · 1994
Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
10.1126/science.7624798 · 1994
p27Kip1 is expressed transiently in developing myotomes and enhances myogenesis
1998
Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
10.1016/s0092-8674(00)81237-4 · 1996
A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice
10.1016/s0092-8674(00)81239-8 · 1996
Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies
1995
Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer
10.1038/nm0297-227 · 1997
Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
10.1038/nm0297-231 · 1997
Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma
1998
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
1997
Cell cycle inhibitory protein p27 in esophageal squamous cell carcinoma
1999
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer
1999
Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is an indicator of malignant behavior in oral squamous cell carcinoma
10.1002/(sici)1097-0142(19981215)83:12<2447::aid-cncr7>3.0.co;2-a · 1998
Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma
10.1002/(sici)1097-0142(19990301)85:5<1011::aid-cncr1>3.0.co;2-0 · 1999
High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(Kip1) and degree of malignancy in human breast and colorectal cancers
10.1073/pnas.94.12.6380 · 1997
Positive correlation between p27Kip1 expression and progression of human esophageal squamous cell carcinoma
10.1002/(sici)1097-0215(19980821)79:4<439::aid-ijc22>3.0.co;2-z · 1998
Unresolved referenced work
Kept as external metadata until matched
Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors
10.1111/j.1600-0714.1992.tb01007.x · 1992
Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan
10.1054/bjoc.2000.1208 · 2000
Unresolved referenced work
1992
Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan
10.1111/j.1600-0714.1998.tb01980.x · 1998
Reduced expression of p27(Kip1) correlates with an early stage of cancer invasion in oral squamous cell carcinoma
10.1016/s0304-3835(99)00419-x · 2000
Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan
10.1111/j.1600-0714.1999.tb02017.x · 1999
Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity
1998
Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer
10.1159/000012067 · 1999
Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx
10.1097/00005537-199908000-00029 · 1999
Expression of p27 is associated with Bax expression and spontaneous apoptosis in oral and oropharyngeal carcinoma
10.1002/(sici)1097-0215(19990621)84:3<315::aid-ijc20>3.0.co;2-u · 1999
Ras activity late in G1 phase required for p27Kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts
10.1128/mcb.17.9.5348 · 1997
Mutation of ki-ras oncogene codon 12 in betel quid chewing-related human oral squamous cell carcinomas in Taiwan
10.1111/j.1600-0714.1994.tb00259.x · 1994
Elevated ras p21 expression in oral premalignant lesions and squamous cell carcinomas in Taiwan
10.1111/j.1600-0714.1995.tb01178.x · 1995
No additional external references are available.